Biosensia




Biosensia is developing a rapid, easy to use, multiplexing Point-of-Care In-vitro Diagnostics platform. The resulting platform, RapiPlex, has combined highly innovative technologies to produce a practical multiplexing IVD platform enabling access to a broad range of diagnostic application. The platform is compatible with a variety of common biological sample types such as whole blood, serum, saliva and urine.

contact
NovaUCD, Belfield, Dublin 4
Telephone:+353 1 7163650
Fax:
Email:info@biosensia.com